Testing For Migraines

Featured Article

The U.S. Food and Drug Administration has decided there is no need for a second study to determine that the migraine drug Levadex is effective. Drugmaker MAP Pharmaceuticals says the orally inhaled migraine med reached all four of its goals in a late-stage study, and the company is now moving forward on remaining clinical trails with a goal of getting the drug approved in late 2010.


Read more

More information on "Testing For Migraines"

From Our Experts

See more SharePosts »

From Our Sources

More on Migraine »